Analysis of the Application Value of P16/Ki-67 Double Staining, TCT Cytology, and HPV Combined Detection Technology in Cervical Lesion Screening
HU Hong-xia
2024, 42(1):
4-7.
Asbtract
(
124 )
PDF (1602KB)
(
39
)
References |
Related Articles |
Metrics
Objective To explore and analysis the application values of P16/Ki-67 double staining, thinprep cytological test (TCT) and human Papilloma (HPV) combined detection technology in screening cervical lesions. Methods From April 2022 to April 2023, 83 cases patients who voluntarily underwent cervical lesion screening and cervical tissue biopsy at our hospital's gynecological outpatient and inpatient clinics were collected as the study subjects. All patients received P16/Ki-67 double staining, TCT cytology, and HPV combined testing, and their positive results were recorded. At the same time, all populations underwent pathological tissue examinations and used them as the diagnostic gold standard to determine the diagnostic value. Results In the 83 patients, pathological examination showed 14 cases of normal tissue, 54 cases of CIN grade 1, 12 cases of CIN grade 2, and 3 cases of CIN grade 3, with high-grade intraepithelial neoplasia accounting for 18.07%. The combined positive rates of normal tissue, CIN 1, CIN 2, and CIN 3 were 4.76%, 10.64%, 66.67%, and 66.67%, respectively. The diagnostic sensitivity of P16/Ki-67 double staining, TCT cytology, and HPV examination for cervical lesions was 66.67% (10/15), 66.67% (10/15), 100.00% (15/15), and 66.67% (10/15), respectively. The diagnostic specificity was 91.18% (62/68), 60.29% (41/68), 17.65% (12/68), and 91.18% (62/68), respectively. Conclusion The P16/Ki-67 double staining, TCT cytology, and HPV combined detection technology can more accurately detect potential high-level lesions in patients, improve the detection rate of cervical lesions, and have good application value.